Tumor necrosis factor alpha (TNF alpha) activates the stress-activated
protein kinases (SAPKs, also known as Jun nuclear kinases or JMKs) re
sulting in the stimulation of AP-1-dependent gene transcription and in
duces the translocation of NF kappa B to the nucleus resulting in the
stimulation of NF kappa B dependent gene transcription, A potential se
cond messenger for these signaling pathways is ceramide, which is gene
rated when TNF alpha activates sphingomyelinases. We show that treatme
nt of HL-60 human promyelocytic cells with exogenous sphingomyelinase
leads to rapid stimulation of JNK/SAPK activity, an effect not mimicke
d by treatment with phospholipase A,, C, or D. Further, JNK/SAPK activ
ity is stimulated 2.7- and 2.8-fold, respectively, in cells exposed to
C-2-ceramide (5 mu M) or TNF alpha (10 ng/ml). The prolonged stimulat
ion of this kinase activity by C-2-ceramide is similar to that previou
sly reported for TNF alpha, In contrast, the related mitogen-activated
protein kinases ERK1 and ERK2 are weakly stimulated following TNF alp
ha treatment (1.5-fold) and are inhibited by C-2-ceramide treatment. T
NF alpha also potently stimulates NF-KB DNA binding activity and trans
criptional activity, but these effects are not mimicked by addition of
C-2-ceramide or sphingomyelinase to intact cells. Furthermore, TNF al
pha, sphingomyelinase, and C-2-ceramide induce c-jun, a gene that is s
timulated by the ATF-S and c-Jun transcription factors, These data sug
gest that ceramide may act as a second messenger for a subset of TNF a
lpha's biochemical and biological effects.